Open Text has 50 per cent upside, National Bank Financial says

A new acquisition for Open Text has National Bank Financial analyst Richard Tse declaring a strong start to fiscal 2019 for Open Text  (Open Text Stock Quote, Chart: TSX, Nasadq:OTEX).

On Wednesday, Open Text announced the acquisition of Liason Technologies for (US) $310-million.

“The acquisition of Liaison is expected to further enhance Open Text’s offerings in digital ecosystem and business-to-business integration solutions as well as application-to-application integration and master data management capabilities,” an anonymous director said. “The proposed acquisition also expands Open Text’s capabilities within key verticals such as life sciences and health care. Additionally, the acquisition enables Open Text to address fast-growing adjacent market segments, including integration platform-as-a-service (iPaaS) with a managed services approach.”

Also Wednesday, OTEX reported its Q1, 2019 results. The company earned (US) $36.36-million on revenue of $667.2-million.

Tse says while there were moving parts in the quarter, the end results met his expectations.

“OpenText reported an essentially in-line fiscal Q1,” Tse says. “While revenue was a touch light, scaling operating margin resulted in an EPS beat. In addition, OpenText announced it had signed a definitive agreement to acquire Liaison Technologies Inc. for ~$310 mln in cash with a target to close in the next 90 days. All in, there was nothing in the quarter that changes our investment thesis. While we estimate organic growth was flat in the quarter, an acquisition at the start of F2019 reaffirms our view. Moreover, we’d call this a strong start to fiscal 2019 when it comes to capital deployment where our estimates were calling $350 mln in acquisitions in F2019.”

In a research update to clients today, Tse maintained his “Outperform” rating and one-year price target of (US) $50.00 on Open Text, implying a return of 50 per cent at the time of publication.

Tse thinks OTEX will generate Adjusted EBITDA of $1.1-billion on revenue of $2.97-billion in fiscal 2019. He expects those numbers will improve to EBITDA of $1.21-billion on a topline of $3.18-billion the following year.

“The reality is that this is not a name that moves linearly, but it’s one where we continue to see meaningful value with some compelling defensive attributes given the recent market backdrop,” Tse adds. “We see a growing base of recurring revenue through acquisitions, expanding operating leverage, and optionality from organic growth. When paired with a flexible balance sheet, it’s no surprise why we continue to rate OTEX an Outperform.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: otex
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago